医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

PotNetwork Holding Inc. Signs Definitive Agreement to Bring Premium CBD into Chinese Consumer Market

2017年04月05日 PM09:00
このエントリーをはてなブックマークに追加


 

FORT LAUDERDALE, Fla.

PotNetwork Holding Inc. (OTC Pink:POTN) is pleased to announce the Company’s subsidiary, Diamond CBD, has entered into an agreement to deliver and distribute its premium cannabidiol (CBD) product line into the thriving China industry, one of the largest consumer markets in the world.

PotNetwork has partnered with a U.S.-based company that provides international business and consulting services, and sources and distributes industrial commodities in China and the Americas. The Company provides a platform to support, develop, and nurture these international business opportunities which will play a vital role in the ongoing globalization of economic activity. The Company possesses a unique ability to identify emerging market opportunities and provide comprehensive solutions or services relevant to conducting international business. With a comprehensive knowledge of the innate practices of Chinese commerce blended with experience within the U.S. and the Americas, the Company offers a compelling advantage enabling capitalization on the growth of the Chinese economy as well as other emerging markets such as Peru, Bolivia, Chile and Ecuador.

The Company will be making its most popular products available including: Diamond’s popular Chill and Relax Gummies, a tasty selection of more than 200 flavored CBD Hemp Oils, Blue CBD Crystals Isolate, Relax Extreme CBD collection, CBD Shots, quality Vape Additives, and more.

“We are thrilled to be stepping into this enormous and advantageous segment of the industry. The incredible opportunities opening before us are a significant indicator of how robust the growth potential is in this sector,” stated Emily Smith, Vice President of Marketing.

China has a consumer base of nearly 1.5 billion people. With equivalent to over 18% of the total world population, consisting of consumers that predominantly embrace homeopathic and natural remedies, forecasts for the newly emerging CBD market in China represent outstanding potential.

Smith concluded, “CBD supplements are so new in the market that forecasts still vary considerably, a perfectly ideal point in time to be bringing our top-quality product line into the market. We are prepared to be a pioneer and choice CBD oil provider that can empower the health conscious Chinese population with top quality premium supplements.”

Having already generated over 1 trillion Yuan in consumer sales, the Chinese nutrition and health product industry is expected to continue rapid growth. Currently, the benefits of CBD oil have not been widely promoted in mainland China. According to ProjectCBD and their examination of peer reviewed articles in scientific journals, CBD oil has been discovered to be effective in reducing anxiety, stress and poor sleep as well as many other ailments such the prevention Alzheimer’s disease, which is prevalent among the aging population which is a segment of the population that has been trending upward in China.

Regarding domestic sales, Diamond CBD recently announced that Management has attained its lofty but anticipated goal of having established a merchandising pipeline of 7,000 authorized retail vendors through its distribution channels. This places Diamond CBD in prime position to provide product access in more than 10,000 stores in the United States.

About Diamond CBD: Diamond CBD, Inc. is an organization focused on the advanced research and development of the industry’s finest premium hemp extracts and making them available to the global marketplace. The Company’s notable team, consisting of hemp industry pioneers and natural product experts, chemists, and scientists, is dedicated to producing the finest and purest Cannabidiol CBD oil. The Company formulates advanced product quality to market through the team’s creation of diverse and top quality hemp extracts that contain a broad profile of cannabinoids and other natural hemp derived molecules, resulting in a robust selection of Industrial Hemp derived Diamond CBD oils considered among the most powerful natural CBD E-Liquids on the market. For more information, please visit the website at www.DiamondCBD.com.

About PotNetwork Holding, Inc: PotNetwork Holding, Inc. (OTC Pink:POTN) is a publicly traded company with two wholly owned subsidiaries, Sunrise Auto Mall Inc. and First Capital Venture Co. and its wholly owned subsidiary Diamond CBD. First Capital Venture Co., through its wholly owned subsidiary Diamond CBD, is a progressive organization focused on the advanced research and development of the industry’s finest premium hemp extracts and making them available to the global marketplace. The Company’s notable team, consisting of hemp industry pioneers and natural product experts, chemists, and scientists, is dedicated to producing the finest and purest CBD oil. For more information, please visit the website at www.DiamondCBD.com.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170405005471/en/

CONTACT

PotNetwork Holding Inc.
Investor Relations:
Marisol Elwell, investor@PotNetworkHolding.com

同じカテゴリーの記事 

  • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer’s Disease and Brain Research Market
  • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report
  • Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China